CEACAM5 has previously been linked to NEPC and has been shown to be an effective target for killing NEPC cells (28, 48) as well as other cancer types such as colorectal and pancreatic cancer (74, 75). Here, CEACAM5 is linked to familial pancreatic carcinoma.